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intervention (PCI).Background The safety of same-day discharge has previously been evaluated primarily in small, single-center studies.Methods We conducted a meta-analysis of studies reporting outcomes of patients discharged on the same day as PCI.
Demographic data, procedural characteristics, and adverse outcomes were collected. Two composite outcomes
were pre-speciﬁed: 1) death, myocardial infarction (MI), or target lesion revascularization (TLR); and 2) major
bleeding or vascular complications.Results Data from 12,803 patients in 37 studies were collated, including 7 randomized controlled trials (RCTs) (n ¼ 2,738)
and 30 observational studies (n ¼ 10,065). The majority of patients in both cohorts underwent PCI for stable angina.
The vascular access site was predominantly transradial in the randomized cohort (60.8%) and transfemoral in the
observational cohort (70.0%). In the RCTs, no difference was seen between same-day discharge and routine
overnight observation with regard to death/MI/TLR (odds ratio [OR]: 0.90; 95% conﬁdence interval [CI]: 0.43 to
1.87; p ¼ 0.78) or for major bleeding/vascular complications (OR: 1.69; 95% CI: 0.84 to 3.40; p ¼ 0.15). In
observational studies, the primary outcome of death/MI/TLR occurred at a pooled rate of 1.00% (95% CI: 0.58% to
1.68%), and major bleeding/vascular complications occurred at a pooled rate of 0.68% (95% CI: 0.35% to 1.32%).Conclusions In selected patients undergoing largely elective PCI, same-day discharge was associated with a low rate of major
complications and appeared to be as safe as routine overnight observation. (J Am Coll Cardiol 2013;62:275–85)
ª 2013 by the American College of Cardiology FoundationPercutaneous coronary intervention (PCI) is performed in
over 500,000 patients in the United States each year (1).
Even elective, uncomplicated PCI has conventionally been
followed by overnight observation, due primarily to concern
about the potential risk of periprocedural adverse events
including acute vessel occlusion, myocardial infarction (MI),
and vascular access complications (2,3). However, with
contemporary percutaneous techniques and anticoagulation
strategies, the risk of major adverse events is low (4,5).
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2012; revised manuscript received February 27,post-procedural period, within 6 h after PCI, rather than
during extended observation (6–9). These factors suggest
that discharge on the same day as PCI may be feasible in
selected patients after an appropriate observation period. In
fact, over the past 15 years, numerous small, single-center
observational studies and single-center, randomized, con-
trolled trials (RCTs) have suggested favorable outcomes
with same-day discharge after PCI (8,10–44). However,
overnight observation remains the standard practice in the
United States (1,19), as none of these studies included
a sample size adequate to evaluate the safety of same-day
discharge. We sought to conduct a meta-analysis to sys-
tematically evaluate the safety of same-day discharge after
PCI in a broad range of patients and practice settings.
Methods
Search strategy. In collaboration with a research librarian,
we performed a comprehensive search of PubMed, SCO-
PUS, and The Cochrane Library (Cochrane Database
of Systematic Reviews and the Cochrane Central Register
Figure 1 Flow Chart of Stu
Flow diagram depicting the selectio
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276of Controlled Trials) in August
2012. We performed key word
searches of the American Heart
Association and American Col-
lege of Cardiology Web sites and
Google Scholar. Finally, we con-
sidered published review arti-
cles, editorials, and Internet-based
sources of information to identify
additional studies. Bibliographies
of retrieved studies were searched
to identify other relevant studies.
The country, author, afﬁliated in-
stitutions, and enrollment periodwere extracted and reviewed to identify and exclude duplicate
publications from the same cohort. The search strategy, study
selection, and analysis adhered to QUORUM (Quality of
Reporting of Meta-Analyses) guidelines for meta-analyses
(45). Further details of the search strategy are provided in
Online Table 1.
Study selection. Human studies published in English were
included if they reported outcomes in patients successfully
discharged on the same day as PCI. We included both RCTs
and observational studies and performed separate analyses
according to study design. Quality assessment of the analyzed
RCTs was performed by Jadad’s method (46). All included
RCTs had a quality score of 3 out of 5 (no studies attempteddy Identiﬁcation and Selection
n strategy for studies included in this meta-analysis.double-blinding), and thus weighting of results was not
performed. Studies that did not report follow-up at 24 h,
those in which transferred patients were sent back to refer-
ring hospitals, and those that included diagnostic coronary
angiography cases only were excluded.
Data extraction. Data were independently extracted by two
reviewers (K.B. and V.P.), and discrepancies were resolved by
consensus. Extracted data included total number of patients,
number eligible for same-day discharge, number actually
discharged, and criteria for deferring discharge among those
eligible for same-day discharge. Variables extracted included
presenting diagnosis; age; sex; past medical history; and
procedural information, including access site, target vessel,
use of glycoprotein IIb/IIIa inhibitors and bivalirudin, and
use of a vascular closure device.
Outcome measures. Outcomes from observational studies
and clinical trials were recorded separately. Outcomes from
clinical trials were collected as intention-to-treat. The two
co-primary composite endpoints were: 1) death, MI, or
target lesion revascularization (TLR); and 2) major bleeding
or vascular complications. Secondary endpoints included
re-admission as well as individual components of the com-
posite endpoints. MI and major bleeding were recorded as
reported in individual trials (see Online Table 2 for deﬁni-
tions in RCTs).
Statistical analysis. For RCTs, data were combined to
estimate the pooled odds ratios (OR) and respective 95%PCI ¼ percutaneous coronary intervention.
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277conﬁdence intervals (CI) for same-day discharge compared
with control. To allow inclusion of trials with zero events,
a “treatment arm” continuity correction was used, with
summary estimates provided by the Mantel-Haenszel
method (47). In observational studies, the cumulative rate
of each outcome for same-day discharge was obtained from
a pooled analysis. Heterogeneity among studies was evalu-
ated with the Cochrane Q (p  0.1 was considered
signiﬁcant) and I2 statistics (25%, 50%, and 75% correlate
with low, moderate, and high heterogeneity, respectively)
for each outcome (48). For outcomes with signiﬁcant het-
erogeneity, a random-effects model as described by Der-
Simonian and Laird was used to obtain a summary estimate
and 95% CI, and is reported in the ﬁgures and text (49).
Begg’s funnel plot was used to assess for publication bias
for the primary composite endpoints in the RCTs (50).
Sensitivity analyses were performed to evaluate the effects
on the primary composite endpoints of excluding studies
that enrolled patients with acute coronary syndromes
(ACS), restricting the analysis to studies performed in the
United States, and restricting the analysis to studies that
used exclusively transfemoral and transradial access. The
impact of potential covariates was examined using meta-
regression where necessary. Data collection, study selec-
tion, processing of the data, and reporting of results were
performed according to accepted principles of systematic
review and meta-analysis (45,51–53). Statistical analyses
were performed using STATA version 11.0 (STATA
Corp., College Station, Texas) with 2-tailed p values <0.05
considered signiﬁcant.
Results
A total of 37 studies were included for analysis (Fig. 1).
Seven RCTs enrolled 2,738 patients between 1999 and
2011, with a mean follow-up of 28.3 days (range: 3–30
days). Two thirds underwent PCI for stable coronary artery
disease (CAD), 27.4% had multivessel CAD, and trans-
radial access was utilized in 60.8% of patients. In addition,
10,065 patients were included in 30 observational studies,
with a mean follow-up of 19.9 days (range: 1–30 days). In
the observational studies, a high proportion of patients
(97.5%) underwent PCI for stable CAD, with transradial
access utilized in 30%, and multivessel CAD found in
28.9%. Baseline characteristics of included patients are
presented in Tables 1 and 2. A comprehensive list of all
included studies is provided in Online Tables 2 and 3. There
was no evidence of publication bias for either primary
endpoint in the RCTs (p ¼ 0.65 for death/MI/TLR;
p ¼ 0.85 for major bleeding/vascular complications).
Randomized controlled trials. Of the 2,738 patients,
1,256 were randomized to same-day discharge and 1,482 to
overnight observation. Among those randomized to same-
day discharge, 87.3% were successfully discharged on the
same day as PCI. Nearly half of the cases of deferral of
same-day discharge occurred in one trial that performed
Table 2 Characteristics of Included Observational Studies
Design/Study/
First Author (Year)
Eligible,
n
Actual,
n Access Presentation Follow-Up Duration
Mean
Age, yrs
Male,
%
MV
Disease,
%
GP
IIb/IIIa, %
LAD PCI,
%
Planned
Time to
D/C, h
Closure
Device, % Primary Outcomes
Prospective
Chaumeil et al.
(2008)
69 40 TR Stable CAD 24 h n/a n/a n/a n/a n/a n/a n/a Death, MI, TVR, re-admission
Corvoisier et al.
(2012)
220 213 TR Stable CAD 24 h, 30 days n/a n/a n/a n/a n/a 6 n/a Death, MI, TVR, vascular
complications/bleeding,
re-admission
Dalby et al.
(2003)
70 51 TF Stable CAD 24 h, 30 days 59 89.5 20.3 10.5 42.9 4 n/a Death, MI, TVR
Khater et al.
(2007)
150 124 TF Stable CAD,
ACS
24 h, 30 days 64 89.5 52.3 0 54.3 4–6 0 Death, MI, TVR, vascular
complications/bleeding
Khatri et al.
(2002)
120 120 TF Stable CAD,
ACS
7 days 65 80.4 n/a 0 41.8 4 100 Death, MI, TVR, vascular
complications/bleeding
Kiemeneij et al.
(1997)
100 92 TR Stable CAD 24 h, 14 days,
30 days
62 89 4 52 n/a n/a n/a Death, MI, TVR, CABG, vascular
complications/bleeding
Kumar et al.
(2004)
150 120 TR Stable CAD 30 days n/a n/a n/a n/a n/a 6 n/a Death, TVR, re-admission
Lasevitch et al.
(2005)
51 51 TF Stable CAD 24 h, 30 days n/a n/a n/a n/a n/a 6 n/a Death, MI, TVR, vascular
complications/bleeding
Muthusamy
et al. (2012)
200 200 TF Stable CAD 24 h, 7 days 59 86.7 31.3 13.6 n/a n/a 0 Death, MI, TVR, stroke, CABG,
vascular complications/
bleeding
Oh et al. (2004) 230 206 TR Stable CAD,
ACS
24 h, 7 days 58 79.8 n/a 0 n/a 10 0 Death, MI, TVR, CABG, vascular
complications/bleeding
Ormiston et al.
(2002)
100 26 TF Stable CAD,
ACS
24 h, 30 days n/a n/a n/a n/a n/a 6 n/a Death, MI, TVR, CABG, vascular
complications/bleeding
Ranchord et al.
(2010)
1,365 1,200 TF Stable CAD 24 h, 30 days n/a n/a n/a n/a n/a n/a n/a Death, MI, TVR, CABG
Ranchord et al.
(2010)
212 179 TF Stable CAD 24 h, 30 days n/a n/a n/a n/a n/a 6 n/a Death, MI, TVR, CABG
Shah et al
(2012)
228 228 TR Stable CAD 30 days 55 66.7 18 75.3 38.2 5 0 Death, MI, TVR, vascular
complications/bleeding
Slagboom et al.
(2001)
159 106 TR Stable CAD 24 h 59 51 n/a 0 35.4 8–12 0 Death, MI, TVR, CABG, vascular
complications/bleeding
Slagboom et al.
(2005)
644 375 TF/TR Stable CAD 24 h, 30 days 63 75 13.5 16 41.3 4-6 60 Death, MI, TVR, CABG, vascular
complications/bleeding
Wilentz et al.
(1999)
50 45 TF Stable CAD,
ACS
24 h, 30 days n/a n/a n/a n/a n/a 9.4* n/a Death, MI, TVR, vascular
complications/bleeding
Yee et al.
(2004)
25 25 TF Stable CAD 2 days, 30 days 61 85 n/a 0 46.9 6 0 Death, MI, TVR, vascular
complications/bleeding
Continued on the next page
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Table 2 Continued
Design/Study/
First Author (Year)
Eligible,
n
Actual,
n Access Presentation Follow-Up Duration
Mean
Age, yrs
Male,
%
MV
Disease,
%
GP
IIb/IIIa, %
LAD PCI,
%
Planned
Time to
D/C, h
Closure
Device, % Primary Outcomes
Retrospective
Antonsen et al.
(2011)
1,809 359 TF Stable CAD,
ACS
24 h, 30 days 57 75.6 n/a 28.2 41 8.2* 90.1 Death, MI, TVR, vascular
complications/bleeding
Banning et al.
(2003)
487 409 TF Stable CAD 30 days 63 88.4 35.8 0 n/a 6 13.7 Death, MI, TVR, CABG
Gilchrist et al.
(2012)
100 100 n/a Stable CAD 24 h, 30 days 62 74.7 n/a 4.2 42.6 6-8 8.5 Death, MI, TVR
Gilchrist et al.
(2002)
26 26 TR Stable CAD,
ACS
24 h, 30 days 77 66.5 n/a 2.4 45.3 6-8 9.9 Death, MI, TVR, readmission
Herman et al.
(2011)
130 130 TR Stable CAD 24 h 73 64.5 n/a 19.3 n/a n/a 65 Death, MI, TVR, readmission
Jabara et al.
(2008)
450 12 TR Stable CAD,
ACS
24 h, 3 days n/a n/a n/a n/a n/a n/a n/a Death, MI, TVR, readmission
Khouri et al.
(2012)
17 17 TF Stable CAD,
ACS
24 h, 14 days 63 80.2 50 0 43 4-6 0 Death, MI, TVR, vascular
complications/bleeding
Patel et al.
(2010)
2,438 2,400 TF Stable CAD 24 h 60 77.3 n/a n/a 41.5 4-6 0 Death, MI, TVR, stroke, vascular
complications/bleeding
Perret et al.
(2009)
95 89 TR Stable CAD,
ACS
24 h, 30 days n/a n/a n/a n/a n/a n/a n/a Death, MI, TVR, vascular
complications/bleeding
Rao et al.
(2011)
1,339 1,339 TF Stable CAD 2 days, 30 days n/a n/a n/a 0 14.3 5.63* 90 Death, re-admission
van Gaal et al.
(2008)
484 463 TF Stable CAD 30 days n/a n/a n/a n/a n/a 9.75* n/a Death, MI, TVR
Wiper et al.
(2006)
442 377 TR Stable CAD 30 days n/a n/a n/a n/a n/a 10 n/a Death, MI, TVR, vascular
complications/bleeding
Ziakas et al.
(2003)
2,072 943 TR Stable CAD 24 h, 30 days 64 79.7 n/a 0 40.8 n/a 0 Death, MI, TVR, re-admission
*Actual time to discharge.
Abbreviations as in Table 1.
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280randomization prior to the PCI procedure (54). Deferral of
same-day discharge in the other trials was due to access site
complications (33%), physician preference (30%), patient
preference (17%), recurrent chest pain (11%), noncardiac
reasons (4.9%), orthostasis (2.4%), and arrhythmias (1.2%).
No difference was observed between same-day discharge
and overnight observation for the primary composite
endpoints of death/MI/TLR (7.17% vs. 6.07%; OR: 0.90;
95% CI: 0.43 to 1.87; p ¼ 0.78) (Fig. 2) or major bleeding/
vascular complications (1.88% vs. 1.29%; OR: 1.69; 95% CI:
0.84 to 3.40; p ¼ 0.15) (Fig. 3). No signiﬁcant differences in
any of the secondary outcomes were observed between the
two arms (Table 3).
In a sensitivity analysis excluding three studies that
enrolled patients with ACS, there were no differences
between same-day discharge and overnight observation for
death/MI/TLR (2.28% vs. 2.94%; OR: 1.02; 95% CI: 0.25
to 4.20; p ¼ 0.98) or for major bleeding/vascular compli-
cations (4.30% vs. 2.46%; OR: 1.57; 95% CI: 0.69 to 3.55;
p ¼ 0.28). Among studies performed in the United States,
there were no differences between groups for either primary
composite endpoint (death/MI/TLR [n ¼ 3 trials], OR:
0.41 [95% CI: 0.05 to 3.19; p ¼ 0.39]; major bleeding/
vascular complications [n ¼ 3 trials], OR: 0.55 [95% CI:
0.12 to 2.52; p ¼ 0.44]). Among studies restricted to
patients undergoing PCI via femoral access, no difference in
major bleeding/vascular complications was seen between
same-day discharge and overnight observation (n ¼ 4 trials;
OR: 0.75; 95% CI: 0.19 to 2.98; p ¼ 0.69), although
a signiﬁcant difference in death/MI/TLR favoring same-dayFigure 2 Pooled Estimate of Composite Endpoint of Death, MI, TLR
CI ¼ conﬁdence interval; MI ¼ myocardial infarction; OR ¼ odds ratio; RCTs ¼ randomizdischarge was found (n ¼ 5 trials; OR: 0.50; 95% CI:
0.20 to 0.90; p ¼ 0.021). This ﬁnding seemed to be driven
predominantly by a signiﬁcant reduction in MI (OR: 0.45,
95% CI: 0.20 to 1.00; p ¼ 0.050). Among studies restricted
to patients undergoing PCI via radial access, there was
no difference for either composite endpoint between same-day
discharge and overnight observation (death/MI/TLR [n ¼ 2
trials], OR: 1.80 [95% CI: 0.50 to 7.40; p ¼ 0.36]; major
bleeding/vascular complications [n ¼ 2 trials], OR: 2.40 [95%
CI: 1.00 to 5.60; p ¼ 0.052]). There was evidence of signif-
icant effect modiﬁcation by access site for death/MI/TLR
(p ¼ 0.04) but not for major bleeding/vascular complications
(p ¼ 0.08).
Observational studies. Of the 14,032 patients described as
eligible for same-day discharge, 10,065 (71.7%) were actu-
ally discharged on the same day. The primary composite
endpoint of death/MI/TLR occurred at a pooled rate of
1.00% (95% CI: 0.58 to 1.68), and major bleeding/vascular
complications occurred at a pooled rate of 0.68% (95% CI:
0.35 to 1.32). Pooled rates of secondary outcomes in the
observational studies are shown in Table 4. There were
15 deaths reported in the same-day discharge group. Of
these, 11 occurred after 24 h; in the remaining 4 cases, the
timing was unclear.
Discussion
We report a comprehensive systematic review and meta-
analysis of outcomes of same-day discharge after PCI,
demonstrating that this approach appears to be safe inin RCTs
ed controlled trials; TLR ¼ target lesion revascularization.
Figure 3 Pooled Estimate of Composite Endpoint of Major Bleeding, Vascular Complications in RCTs
Abbreviations as in Figure 2.
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281carefully selected patients across a range of domestic and
international practice settings. Although same-day discharge
in selected patients after elective PCI has been considered
for almost 15 years, the United States has been slow to
implement this strategy in routine practice (55). A number
of barriers to adoption have been identiﬁed, with concerns
espoused primarily about safety, feasibility, patient prefer-
ences, and cost considerations (56–59).
An advantage of meta-analysis is that it offers the
opportunity to evaluate the risk of rare adverse events that
individual studies may be underpowered to adequately
ascertain. Pooled adverse event rates were very low in the
observational studies. Although event rates were higher in
the RCTs, when studies that enrolled patients with ACS
were excluded, the event rates were markedly lower and were
comparable to those seen in the observational studies. Higher
event rates in the RCTs were due to an excess of MI events
in one trial (13) that included ACS patients and incorporated
routine biomarker measurement, leading to a high number of
periprocedural MI diagnoses in both treatment groups.
Although the RCT meta-analysis yields a higher level of
evidence, the observational meta-analysis provides comple-
mentary information about the safety of same-day discharge
in a real-world context and across a much larger pool of
patients than the RCTs. It is important to note that patients
with signiﬁcant comorbidities were excluded from most of
these studies. For example, patients with left ventricular
ejection fraction <30% (15,18,21) and those with chronic
kidney disease (12,15,18,21) were excluded from mostclinical trials. These conditions have been shown to predict
periprocedural complications of PCI (60–63), and patients
with these comorbidities are unlikely to be ideal candidates
for same-day discharge even if PCI is elective. Thus, while
the aggregate ﬁndings from this meta-analysis provide
support for the safety of same-day discharge, the caveat
remains that these ﬁndings were derived from carefully
selected patients.
Early studies of same-day discharge after PCI were per-
formed by international centers that routinely use bleeding-
mitigation strategies such as transradial access and avoidance
of glycoprotein IIb/IIIa inhibitors, and as such, concerns
were raised regarding application to U.S. practice (56,64).
However, our sensitivity analysis limited to U.S.-based trials
showed no difference in either primary endpoint between
the same-day discharge group and overnight observation.
Further, major bleeding and vascular complications were
similar between same-day discharge and overnight obser-
vation in trials using transfemoral access only. These sensi-
tivity analyses support the application of our ﬁndings to
U.S.-based practicesdeven ones using primarily trans-
femoral access. Differences in outcomes based on access site
noted in this analysis are hypothesis generating and require
further study.
Skepticism has been expressed about the willingness
of U.S. patients to accept same-day discharge (56). A
number of the studies included in our analysis speciﬁ-
cally queried patients regarding their satisfaction with
same-day discharge, each reporting high satisfaction rates
Table 4 Outcomes in Observational Studies
Outcome
No. of
Studies
Cumulative
Rate, n/N
Pooled
Estimate, % 95% CI
Death þ MI þ TLR* 27 65/8,043 1.00 0.58–1.68
Death 31 15/10,065 0.48 0.33–0.71
MI* 27 24/8,043 0.75 0.34–1.68
TLR* 28 32/8,163 0.79 0.42–1.47
Re-admission* 29 305/9,227 2.25 1.43–3.55
CABG 26 6/7,884 0.39 0.24–0.62
Stroke 15 4/5,091 0.52 0.24–1.14
Major bleeding þ
vascular
complications*
22 12/6,160 0.68 0.35–1.32
Major bleeding 23 1/6,559 0.43 0.25–0.77
Vascular
complications*
26 16/7,703 0.63 0.35–1.13
Minor bleeding* 22 19/6,467 2.12 1.23–3.65
*I2 > 25%.
Abbreviations as in Table 1.
Table 3 Outcomes in Randomized Controlled Trials
Outcome
No. of
Studies
Same-Day
Discharge, n/N Control, n/N OR 95% CI p Value
Death þ MI þ TLR 7 90/1,256 90/1482 0.90 0.43–1.87 0.78
Death 7 0/1,256 2/1482 0.63 0.16–2.45 0.50
MI 7 80/1,256 80/1482 1.01 0.73–1.40 0.94
TLR 7 10/1,256 8/1482 1.18 0.53–2.65 0.69
Re-admission 7 73/1,256 70/1482 1.04 0.74–1.46 0.81
Stroke 4 0/683 2/911 0.60 0.10–3.67 0.58
Major bleeding þ vascular complications 6 16/853 14/1085 1.69 0.84–3.40 0.15
Major bleeding 6 4/853 1/1085 1.88 0.51–6.95 0.35
Vascular complications 7 15/1,256 17/1482 1.27 0.65–2.46 0.49
Minor bleeding 6 91/1,233 78/1461 1.18 0.86–1.64 0.31
CI ¼ conﬁdence interval; OR ¼ odds ratio; other abbreviations as in Table 1.
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282(11,12,14,15,18,24,27,31,34,44,54). However, we were un-
able to meaningfully combine the results given marked
heterogeneity in the instruments used in the trials. The
satisfaction data are also likely heavily biased given that
patients included in the studies had to be willing to undergo
same-day discharge. Finally, there was no comparator group
in the observational studies. Thus, the most one could say
with respect to the patient satisfaction data is that among
patients initially willing to consider same-day discharge, the
included trials demonstrated a numerically high level of
patient satisfaction.
Although the ﬁnancial implications are complex, same-
day discharge could represent an important cost-saving
strategy for both hospitals and the health system. The
Centers for Medicare and Medicaid Services generally
reimburse elective PCI as an outpatient procedure, deﬁned
as a hospital stay of 23 h (65,66); the hospital receives the
same reimbursement regardless of when the patient is dis-
charged during this period. A potential ﬁnancial incentive
may thus exist for hospitals that avoid overnight observation,
as reported by several centers (12,24,27). When extrapolated
to the U.S. healthcare system at large, the savings from
same-day discharge could be substantial (67,68). However,
the ability of a hospital to realize ﬁnancial beneﬁt from
same-day discharge depends at least in part on whether the
hospital can proﬁtably re-allocate the resources liberated in
discharging the patient on the day of the procedure. A
formal cost-effectiveness analysis is necessary to fully
understand the ﬁnancial impact of the practice.
Demonstrating the safety of same-day discharge in
selected patients after elective PCI is a necessary ﬁrst step in
considering implementation. However, it must be empha-
sized that the RCTs and prospective cohorts in our study
each had explicit inclusion and exclusion criteria that iden-
tiﬁed a relatively low-risk cohort of patients for consider-
ation of same-day discharge (e.g., having undergone an
uncomplicated procedure, and/or residing within a certain
proximity to the performing center) and allowed triage
to overnight observation where appropriate. All studies
required an observation period prior to discharge, as well as
a protocol for short-term follow-up with patients who weresuccessfully discharged. Centers planning to implement
a same-day discharge program should develop formal criteria
for the identiﬁcation of appropriate patients as well as a
system for close follow-up. A suggested same-day discharge
protocol is provided in Figure 4. The Society for Cardio-
vascular Angiography and Interventions and the American
College of Cardiology Foundation released a consensus
statement in 2009 identifying patients suitable for out-
patient PCI procedures; however, these were primarily
based on a few small, single-center studies and relied
heavily on expert consensus. Recommendations for same-
day discharge have not yet been incorporated into the
American Heart Association/American College of Cardi-
ology PCI guidelines (69).
Although one recent meta-analysis by Abdelaal et al. (70)
evaluated the safety and feasibility of same-day discharge
after uncomplicated PCI, our meta-analysis differs in
several important respects. First, the present analysis
includes one additional randomized trial and 23 additional
observational studies. Second, our separate meta-analysis of
observational studies includes only those patients who were
actually discharged on the day of PCI. This is a signiﬁcant
Figure 4 Sample Protocol for a Same-Day Percutaneous Coronary Intervention Program
CTO ¼ chronic total occlusion; EF ¼ ejection fraction; GFR ¼ glomerular ﬁltration rate; PCI ¼ percutaneous coronary intervention.
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283methodological difference from the study by Abdelaal et al.
(70), which included patients not discharged as a post hoc
“control” arm. Given the well-described problems of se-
lection bias and confounding that emerge when observational
data are used to compare therapies directly, observational
data should generally not be relied on to compare outcomes
when randomized data are available (71–73). Finally, our
analysis includes a safety endpoint speciﬁcally focused on
vascular complications and bleeding in addition to the
composite major adverse cardiac events outcome, which is
clinically important.
Study limitations. As patient-level data were not available,
only adverse outcomes that were clearly reported in each
study were included, which may have led to over- or
underreporting of complications. It was not always possible
to discern whether an adverse event in the same-day
discharge group occurred more than 24 h after discharge,
and thus would not necessarily have been modiﬁable by
overnight observation. A number of the retrospective studies
performed telephone follow-up for the assessment of
outcomes, which may have led to bias in the reporting of
events. The majority of the included studies were observa-
tional, with inherent risks of selection bias. However, the
observational studies were included only to provide a real-
world estimation of risks; all effect estimates are from
RCTs. Even with pooling of RCTs, our analysis was
underpowered to study most individual clinical outcomes.For this reason, our primary outcomes were composite
endpoints; despite this, our study provided limited power to
detect small differences between treatment groups.Conclusions
Although larger studies are needed to provide deﬁnitive
comparisons of same-day discharge versus overnight obser-
vation, in aggregate the data from RCTs and observational
studies support the consideration of programs for same-day
discharge in carefully selected patients.
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